National Cancer Institute  www.cancer.gov  U.S. National Institutes of Health
 


Cancer Trends Progress Report – 2011/2012 Update

Skip to content
Progress Report  Home

Progress Report
Tools and Resources
  Appendices
  Data Sources (PDF)
  Dictionary
  Fact Sheet (PDF)
  FAQs
 Generate custom report
 Print this page
  Quick Tutorial
  Report Archive



In the Report
Director's Message
Report Highlights
Introduction
Trends-at-a-Glance
Summary Tables
Prevention
Smoking
Clinicians’ Advice to Quit Smoking
Medicaid Coverage of Tobacco Dependence Treatments
Diet
Weight and Physical Activity
Sun Protection
Secondhand Smoke
Chemical Exposures
Tobacco Company Marketing Expenditures
Early Detection
Breast and Cervical Cancers
Colorectal Cancer
Diagnosis
Treatment
Bladder, Breast, Colorectal
Kidney, Lung, Ovarian, Prostate
Life After Cancer
End of Life
Prevention
Early Detection
Diagnosis
Treatment
Life After Cancer
End of Life


Summary Table: Treatment – Bladder, Breast, Colorectal

Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found in the report.

Trend key: green - headed in the right direction
  red - headed in the wrong direction
  black - stable or non-significant change (NSC)
  blue - Healthy People 2020 target


  Bladder cancer treatment
1995–2003
Breast cancer treatment:
Breast-conserving surgery and radiation
1992–2008
Breast cancer treatment:
Multi-agent chemotherapy
1987–2005
Colorectal cancer treatment
1987–2005
Measure Percentage of individuals receiving intravesical therapy in non-muscle invasive bladder cancer. Percentage of women aged 20 years and older, diagnosed with early-stage breast cancer (less than stage IIIA), receiving breast-conserving surgery and radiation treatment. Percentage of women aged 20 years and older, diagnosed with node positive, stage I–IIIa breast cancer, receiving multi-agent chemotherapy. Percentage of individuals ages 20 years and older, who were diagnosed with stage III colon cancer and received chemotherapy, or were diagnosed with stage II or stage III rectal cancer and received chemotherapy with or without radiotherapy.
Recent summary trend* Rising
1995–2003
Falling
2004–2008
Rising
2001–2005
Rising
2001–2005
Desired direction
Rising 
Rising 
Rising 
Rising 
Trend Rising


Non-significant change, then falling, then non-significant change, then falling
Rising


Rising


Most recent estimate In 2003, 27 percent of patients with non-muscle invasive disease received intravesical therapy. New estimates will be available in 2013. In 2008, 35 percent of women ages 20 years and older diagnosed with early-stage breast cancer (less than stage IIIA) received mastectomy, 41 percent received breast-conserving surgery plus radiation, and 19 percent received breast-conserving surgery only. In 2005, 67 percent of women aged 20 years and older, diagnosed with node positive breast cancer, received multi-agent chemotherapy. In 2005, 60 percent of stage III colon and stage II and III rectal patients aged 65 years and older received adjuvant chemotherapy, while more than 85 percent of patients aged 20 to 64 received chemotherapy. A colorectal patterns of care study is currently being conducted for diagnosis year 2010.
Healthy People 2020 target There are no Healthy People 2020 targets for cancer treatment, including bladder cancer treatment. There are no Healthy People 2020 targets for cancer treatment, including breast cancer treatment. There are no Healthy People 2020 targets for cancer treatment, including breast cancer treatment. There are no Healthy People 2020 targets for cancer treatment, including colorectal cancer treatment.
More information Bladder Cancer Treatment Breast Cancer Treatment Colorectal Cancer Treatment

Previous: Diagnosis

Next: Treatment - Kidney, Lung, Ovarian, Prostate

National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthUSA.gov

NIH... Turning Discovery Into Health